| # | Drug | Count |
|---|---|---|
| 0 | CAPECITABINE | 1863 |
| 1 | FULVESTRANT | 1779 |
| 2 | LETROZOLE | 1699 |
| 3 | LETROZOLE TABLETS | 1357 |
| 4 | EVEROLIMUS | 1272 |
| 5 | PACLITAXEL | 1190 |
| 6 | RIBOCICLIB | 1150 |
| 7 | BEVACIZUMAB | 1149 |
| 8 | PACLITAXEL (AIBUMIN-BOUND) | 1019 |
| 9 | FLUOROURACIL | 946 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXTRAN 40 | 8 | 0.1111 |
| 1 | FULVESTRANT | 1779 | 0.0531 |
| 2 | VINORELBINE | 254 | 0.0365 |
| 3 | RADIUM RA 223 DICHLORIDE | 179 | 0.0354 |
| 4 | EXEMESTANE | 758 | 0.0352 |
| 5 | RIBOCICLIB | 1150 | 0.0352 |
| 6 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 5 | 0.0333 |
| 7 | GOSERELIN | 451 | 0.0332 |
| 8 | STREPTOZOCIN | 7 | 0.0304 |
| 9 | EVEROLIMUS TABLETS | 517 | 0.0302 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 2967 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 2690 |
| 2 | Aromatase Inhibitor [EPC] | 2530 |
| 3 | Platinum-based Drug [EPC] | 2063 |
| 4 | Estrogen Receptor Antagonist [EPC] | 1834 |
| 5 | Microtubule Inhibitor [EPC] | 1755 |
| 6 | mTOR Inhibitor Immunosuppressant [EPC] | 1302 |
| 7 | Corticosteroid [EPC] | 1248 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1198 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1024 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 1834 | 0.0452 |
| 1 | Aromatase Inhibitor [EPC] | 2530 | 0.0222 |
| 2 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 23 | 0.0212 |
| 3 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 11 | 0.0183 |
| 4 | Somatostatin Analog [EPC] | 106 | 0.0154 |
| 5 | Provitamin D2 Compound [EPC] | 371 | 0.0125 |
| 6 | Epidermal Growth Factor Receptor Antagonist [EPC] | 571 | 0.0121 |
| 7 | Interleukin-5 Antagonist [EPC] | 8 | 0.0116 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 835 | 0.0112 |
| 9 | Microtubule Inhibitor [EPC] | 1755 | 0.0106 |